ZAVANTE THERAPEUTICS
Zavante is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.
ZAVANTE THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.zavante.com
Total Employee:
11+
Status:
Active
Contact:
(858)705-2365
Email Addresses:
[email protected]
Total Funding:
65 M USD
Technology used in webpage:
Microsoft Twitter Tweet Button Facebook Like Button Facebook Like Corporation Service Company
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Rapt Therapeutics
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
Horizon Pharma
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
NFlection Therapeutics
NFlection focuses on the development of novel therapies to address the needs of patients.
Opterion Health
Opterion Health is focused to bring innovation to dialysis care and foster home dialysis to improve the quality of life for patients.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Sarcio
Sarcio uses regenerative cartilage cell therapy to treat patients suffering from the effects of Osteoarthritis.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Visgenx
Visgenx develops therapeutics to protect against the loss of sight from retinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Mesa Verde Venture Partners
Mesa Verde Venture Partners investment in Venture Round - Zavante Therapeutics
Square 1 Bank
Square 1 Bank investment in Debt Financing - Zavante Therapeutics
Longitude Capital
Longitude Capital investment in Series A - Zavante Therapeutics
Aisling Capital
Aisling Capital investment in Series A - Zavante Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Zavante Therapeutics
Global Source Ventures
Global Source Ventures investment in Series A - Zavante Therapeutics
Square 1 Bank
Square 1 Bank investment in Venture Round - Zavante Therapeutics
More informations about "Zavante Therapeutics"
Zavante Therapeutics - Crunchbase Company Profile & Funding
Organization. Zavante Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Zavante is a clinical-stage …See details»
Zavante Company Profile 2024: Valuation, Investors, Acquisition
Zavante General Information Description. Developer of novel medicines for the treatment of diseases that affect patients in the hospital setting. The company's lead product candidate is …See details»
Zavante Therapeutics, Inc. Information - RocketReach
Zavante is a clinical-stage biopharmaceutical company Our Mission: to improve patients’ lives by identifying, developing and commercializing novel therapeutics addressing significant unmet …See details»
Zavante Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... 1 — — Sep 1, 2016: Debt Financing - Zavante …See details»
Zavante Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zavante Therapeutics, Inc. of King OF Prussia, PA. Get the latest business insights from Dun & …See details»
New Antibiotics | Nabriva Therapeutics | Nabriva.com
The new organization included small molecule assets, including pleuromutilin structure activity relationships (SAR) knowledge, and focused on synthesis of pleuromutilins for systemic …See details»
Zavante Therapeutics - Contacts, Employees, Board Members
Organization. Zavante Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Zavante Therapeutics has 1 …See details»
Commercial Stage Biopharmaceutical Company | Nabriva.com
Nabriva is a commercial-stage biopharmaceutical company engaged in the research & development of novel antibiotics to treat serious infections, with a current focus on the …See details»
Zavante Therapeutics - VentureRadar
Zavante is a late clinical-stage biopharmaceutical company focused on licensing, developing and commercializing novel products that address serious unmet medical needs in the hospital. …See details»
Zavante Therapeutics Inc - Company Profile and News
Company profile page for Zavante Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Nabriva Acquires Zavante Therapeutics and its Late-Stage Antibiotic
Jul 25, 2018 Shares of Nabriva Therapeutics are rising this morning after the company announced it acquired privately-held Zavante Therapeutics in an all-stock deal that will bring …See details»
Duties and Responsibilities - zavante.com
Change and product learnings to the commercialization organization to inform, shape and redirect product development efforts as needed • Demonstrated ability working with numerous external …See details»
Nabriva Corporate > About Nabriva > Our Products - zavante.com
© Nabriva Therapeutics plc, Ireland Registration No. 599588, 25-28 North Wall Quay, Dublin 1, IrelandSee details»
Zavante Therapeutics - Crunchbase
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.See details»
Avante! Startup Zavante heads for FDA with revamped antibiotic
Apr 6, 2017 The overall treatment success rate with Zavante's drug was 64.7%, higher than the 54.5% response rate with the standard therapy, and clinical cure rates were above 90% in …See details»
GAIN Act gives Zavante a shot at new antibiotic development
Apr 6, 2017 Zavante Therapeutics, a 2013 startup based in California, is repurposing an old oral antibiotic widely used in Europe as a U.S. intravenous drug. "One of the challenges with …See details»
Zavante Therapeutics Closes $45 Million Series A Financing In …
SAN DIEGO, March 30, 2016 /PRNewswire/ -- Zavante Therapeutics, Inc., a privately held, late clinical-stage biopharmaceutical company, today announced that it has closed a $45 million …See details»
Zavante Therapeutics - Tech Stack, Apps, Patents & Trademarks
Zavante Therapeutics uses 21 technology products and services including Office 365, DigiCert, and Wordpress, according to G2 Stack. Zavante Therapeutics is actively using 9 technologies …See details»
Zavante acquisition doubles Nabriva chances of commercializing …
Aug 23, 2018 In addition, Zavante’s former stockholders are eligible to receive up to $97.5 million upon the achievement of specified regulatory and commercial milestones, Along with …See details»
Upstart Zavante raises $45M, takes aim at a pivotal antibiotic study
Mar 29, 2016 San Diego-based Zavante Therapeutics has raised $35 million--adding it to an additional $10 million from convertible debt for the Series A round--to back a pivotal study …See details»